MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma
07:30am - 03:45pm EDT - March 31, 2023
07:30am - 03:45pm EDT - March 31, 2023
Author(s):
- Nguyen H. Tran, MD, Assistant Professor of Oncology, Mayo Clinic Comprehensive Cancer Center
Tags: Member Institution Clinical Oncology ORP
| Display Label | Action |
|---|---|
| NCCN_poster_final.pdf | Download Handout |
| AC23P29 - MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib in Combination with Pembrolizumab in Patients with FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma | Download MP3 |
